MD-224

MD-224


MD-224 is a novel PROTAC-based small molecule designed to specifically degrade the MDM2 proto-oncogene. As a pioneering and highly effective degrader, MD-224 represents a new class of anticancer agents with significant potential in targeted therapy. Functioning as a click chemistry reagent, it harbors an alkyne group, enabling it to engage in copper-catalyzed azide-alkyne cycloaddition (CuAAC) with molecules featuring Azide groups.

Molecular structure of the compound BP-41600
    • Unit
    • Price
    • Qty
    • 5 MG
    • $280.00
    • 10 MG
    • $530.00
    • 25 MG
    • $950.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire